StockData
CVS HEALTH Corp logo

CVS HEALTH Corp

CVSNYSERetail-Drug Stores and Proprietary StoresFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/3014% above fair value
$88.51−1.74 (-1.93%)

Close on Nov 2, 2026Market cap $113.20BP/E 23.5Yield 3.01%

Cvs Health AFS Debt Securities Maturing in 5 to 10 Years by Quarter

AFS Debt Securities Maturing in 5 to 10 Years (Fair Value) ($M)

QuarterlyAnnual

Cvs Health AFS Debt Securities Maturing in 5 to 10 Years: $5,880M in Q2 2026, up 28.8% from a year earlier. That is the highest of the 30 quarters on record here.

Latest, Q2 2026
5,880
Period ended Jun 30, 2026
Change on a year earlier
+28.8%
4,564 in Q2 2025
History
30 quarters
Since Q4 2018
Sources
2
Documents cited below

Where the Q2 2026 figure comes from

Source: CVS SEC 10-Q (XBRL us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue) ↗

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedAFS Debt Securities Maturing in 5 to 10 Years (Fair Value) ($M)Year on yearSource
Q2 2026Jun 30, 20265,880+28.8%CVS SEC 10-Q (XBRL us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue) ↗
Q1 2026Mar 31, 20265,685+29.6%CVS SEC 10-Q (XBRL us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue) ↗
Q4 2025Dec 31, 20255,382+17.6%CVS SEC 10-K (XBRL us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue) ↗
Q3 2025Sep 30, 20254,783-2.2%CVS SEC 10-Q (XBRL us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue) ↗
Q2 2025Jun 30, 20254,564+6.4%CVS SEC 10-Q (XBRL us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue) ↗
Q1 2025Mar 31, 20254,385-1.7%CVS SEC 10-Q (XBRL us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue) ↗
Q4 2024Dec 31, 20244,578+8.9%CVS SEC 10-K (XBRL us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue) ↗
Q3 2024Sep 30, 20244,890+25.7%CVS SEC 10-Q (XBRL us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue) ↗
Q2 2024Jun 30, 20244,288+5.1%CVS SEC 10-Q (XBRL us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue) ↗
Q1 2024Mar 31, 20244,463+3.8%CVS SEC 10-Q (XBRL us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue) ↗
Q4 2023Dec 31, 20234,204-4.5%CVS SEC 10-K (XBRL us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue) ↗
Q3 2023Sep 30, 20233,891-10.5%CVS SEC 10-Q (XBRL us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue) ↗
Q2 2023Jun 30, 20234,078-10.6%CVS SEC 10-Q (XBRL us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue) ↗
Q1 2023Mar 31, 20234,299-13.4%CVS SEC 10-Q (XBRL us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue) ↗
Q4 2022Dec 31, 20224,401-10.4%CVS SEC 10-K (XBRL us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue) ↗
Q3 2022Sep 30, 20224,347-7.9%CVS SEC 10-Q (XBRL us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue) ↗

Cite this data

StockData. (2026). Cvs Health AFS Debt Securities Maturing in 5 to 10 Years ($M), quarterly Q4 2018–Q2 2026 [Data set]. Compiled from Cvs Health SEC filings and investor materials. https://stockdatahq.com/stocks/cvs/kpis/inv-afs-mat-5-to-10y

See every metric in the Cvs Health KPI table. Data updated Oct 28, 2026.